- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
XSpray Pharma AB (XSPRAY)
XSpray Pharma AB stock price live, this page displays ST XSPRAY stock exchange data. View the XSPRAY premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the XSpray Pharma AB real time stock price chart below.
What Is the XSpray Pharma AB Stock Price Today?
The XSpray Pharma AB stock price today is 42.80.
What Is the Stock Symbol for XSpray Pharma AB?
The stock symbol for XSpray Pharma AB is ""XSPRAY.""
What Stock Exchange Does XSpray Pharma AB Trade On?
XSpray Pharma AB is listed and trades on the Stockholm stock exchange.
Is XSpray Pharma AB a Good Stock to Buy?
Determining whether XSpray Pharma AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the XSPRAY quote. (ISIN: SE0009973563)
What Is the XSpray Pharma AB Stock Price Today?
The XSpray Pharma AB stock price today is 42.80.
What Is the Stock Symbol for XSpray Pharma AB?
The stock symbol for XSpray Pharma AB is ""XSPRAY.""
What Stock Exchange Does XSpray Pharma AB Trade On?
XSpray Pharma AB is listed and trades on the Stockholm stock exchange.
Is XSpray Pharma AB a Good Stock to Buy?
Determining whether XSpray Pharma AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the XSPRAY quote. (ISIN: SE0009973563)
Stockholm
Currency in SEK
42.80
-1.45(-3.28%)
Closed·
Fair Value
An estimate of a XSpray Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
42.80
45.20
52 wk Range
23.00
65.60
XSPRAY Scorecard
Full Analysis
Suffers from weak gross profit margins
XSPRAY is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a XSpray Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
42.8045.20
52 wk Range
23.0065.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
XSPRAY Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a XSpray Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
88.00
Upside
+105.61%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Short term obligations exceed liquid assets
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
XSpray Pharma AB Company Profile
Xspray Pharma AB (publ), a pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden. The company develops Dasynoc, an amorphous version of dasatinib for the treatment of chronic myeloid leukemia (CML)and acute lymphoblastic leukemia; XS003, an amorphous non-crystalline nilotinib for the treatment of CML; XS008, an axitinib for the treatment of kidney cancer; and XS025, a amorphous non-crystalline cabozantinib for the treatment of renal cell carcinoma and other cancers. It has partnership agreements with EVERSANA for the commercialization of Dasynoc, as well as with NerPharMa S.r.l for production of Dasynoc. The company was formerly known as Xspray Microparticles AB and changed its name to Xspray Pharma AB (publ) in 2017. Xspray Pharma AB (publ) was incorporated in 2003 and is headquartered in Solna, Sweden.
Compare XSPRAY to Peers and Sector
Metrics to compare | XSPRAY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipXSPRAYPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.5x | −5.1x | −0.6x | |
PEG Ratio | 2.61 | −0.06 | 0.00 | |
Price/Book | 3.1x | 5.1x | 2.6x | |
Price / LTM Sales | - | 41.5x | 3.3x | |
Upside (Analyst Target) | 98.9% | 29.1% | 39.0% | |
Fair Value Upside | Unlock | 10.9% | 4.9% | Unlock |
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 88.00
(+105.61% Upside)
Earnings
Latest Release
Aug 15, 2025
EPS / Forecast
-1.18 / -1.71
Revenue / Forecast
1.30M / --
FAQ
What Stock Exchange Does XSpray Pharma Trade On?
XSpray Pharma is listed and trades on the Stockholm Stock Exchange stock exchange.
What Is the Stock Symbol for XSpray Pharma?
The stock symbol for XSpray Pharma is "XSPRAY."
What Is the XSpray Pharma Market Cap?
As of today, XSpray Pharma market cap is 1.60B.
What Is XSpray Pharma's Earnings Per Share (TTM)?
The XSpray Pharma EPS (TTM) is -7.04.
When Is the Next XSpray Pharma Earnings Date?
XSpray Pharma will release its next earnings report on 04 Nov 2025.
From a Technical Analysis Perspective, Is XSPRAY a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has XSpray Pharma Stock Split?
XSpray Pharma has split 0 times.
How Many Employees Does XSpray Pharma Have?
XSpray Pharma has 26 employees.
What is the current trading status of XSpray Pharma (XSPRAY)?
As of 26 Aug 2025, XSpray Pharma (XSPRAY) is trading at a price of 42.80, with a previous close of 44.25. The stock has fluctuated within a day range of 42.80 to 45.20, while its 52-week range spans from 23.00 to 65.60.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.